All In Biotech

Free tool

FAERS Monitor: Aldurazyme

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125058 or its brand name (Aldurazyme, Laronidase). Reports on generic versions are filed under their own applications.

Reports

4,133

Serious

2,841

69% of reports

Hospitalization

1,423

Death reported

671

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pyrexia517
  • pneumonia246
  • vomiting207
  • dyspnoea198
  • malaise190
  • cough187
  • fatigue151
  • death141
  • headache133
  • influenza131
  • pain128
  • condition aggravated127
  • inappropriate schedule of product administration119
  • urticaria118
  • nasopharyngitis107

Reports by year received

View as table
YearReports
200481
200560
200628
2007111
200861
200959
201051
201173
201290
2013132
2014133
2015208
2016249
2017264
2018325
2019261
2020259
2021317
2022353
2023371
2024257
2025202
2026188

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,026 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pyrexiaSignal5177.67.03,009
influenzaSignal1316.05.1541
pneumoniaSignal2463.93.4528
urticariaSignal1183.63.0219
coughSignal1873.43.0318
inappropriate schedule of product administrationSignal1193.42.8197
nasopharyngitisSignal1073.02.5138
vomitingSignal2072.22.0144
malaiseSignal1902.21.9127
condition aggravatedSignal1272.11.876
dyspnoea1981.81.669
headache1331.10.91
pain1281.10.90
fatigue1511.00.80
death1410.80.75

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.